Tomotaka Mabuchi

2.1k total citations
72 papers, 1.4k citations indexed

About

Tomotaka Mabuchi is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Tomotaka Mabuchi has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 30 papers in Dermatology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Tomotaka Mabuchi's work include Psoriasis: Treatment and Pathogenesis (30 papers), Dermatology and Skin Diseases (18 papers) and Asthma and respiratory diseases (8 papers). Tomotaka Mabuchi is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (30 papers), Dermatology and Skin Diseases (18 papers) and Asthma and respiratory diseases (8 papers). Tomotaka Mabuchi collaborates with scholars based in Japan, United States and Australia. Tomotaka Mabuchi's co-authors include Tomonori Takekoshi, Sam T. Hwang, Akira Ozawa, Hidetoshi Inoko, Samuel Hwang, Akira Ozawa, Akira Oka, Shigaku Ikeda, Keiji Iwatsuki and N. Hirayama and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Tomotaka Mabuchi

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomotaka Mabuchi Japan 20 1.0k 638 219 200 185 72 1.4k
Satveer K. Mahil United Kingdom 18 1.1k 1.1× 675 1.1× 227 1.0× 171 0.9× 178 1.0× 45 1.5k
Antonella Di Cesare Italy 13 1.2k 1.1× 733 1.1× 226 1.0× 145 0.7× 238 1.3× 38 1.6k
Hekla Sigmundsdóttir Iceland 14 1.2k 1.2× 520 0.8× 231 1.1× 222 1.1× 378 2.0× 21 1.9k
Pablo Coto‐Segura Spain 18 656 0.6× 427 0.7× 136 0.6× 201 1.0× 144 0.8× 60 1.1k
Luis F. Santamaria‐Babí Spain 27 1.0k 1.0× 839 1.3× 353 1.6× 312 1.6× 166 0.9× 68 1.9k
Melodie Young United States 15 1.0k 1.0× 575 0.9× 141 0.6× 134 0.7× 245 1.3× 41 1.3k
Luca Potestio Italy 25 778 0.8× 839 1.3× 207 0.9× 138 0.7× 220 1.2× 114 1.4k
Gamze Pişkin Netherlands 12 979 1.0× 629 1.0× 251 1.1× 118 0.6× 114 0.6× 17 1.2k
Inna Cueto United States 18 895 0.9× 936 1.5× 383 1.7× 167 0.8× 108 0.6× 27 1.6k
Sabatino Pallotta Italy 18 1.1k 1.1× 679 1.1× 226 1.0× 278 1.4× 325 1.8× 53 1.9k

Countries citing papers authored by Tomotaka Mabuchi

Since Specialization
Citations

This map shows the geographic impact of Tomotaka Mabuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomotaka Mabuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomotaka Mabuchi more than expected).

Fields of papers citing papers by Tomotaka Mabuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomotaka Mabuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomotaka Mabuchi. The network helps show where Tomotaka Mabuchi may publish in the future.

Co-authorship network of co-authors of Tomotaka Mabuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomotaka Mabuchi. A scholar is included among the top collaborators of Tomotaka Mabuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomotaka Mabuchi. Tomotaka Mabuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Gang, et al.. (2024). Epidemiological analysis of the patients with psoriasis in Asian countries and region using the same clinical case cards between 2020 and 2022. The Journal of Dermatology. 51(4). 567–583. 7 indexed citations
2.
Mabuchi, Tomotaka, et al.. (2023). Case of Exacerbation of Psoriasis Following COVID-19 Vaccination During Treatment with Brodalumab, Which Resulted in Secondary Failure.. PubMed. 48(4). 136–138. 1 indexed citations
3.
Shi, Zhenrui, Tomotaka Mabuchi, Xuesong Wu, et al.. (2023). The Chemokine, CCL20, and Its Receptor, CCR6, in the Pathogenesis and Treatment of Psoriasis and Psoriatic Arthritis. PubMed. 8(3). 107–117. 2 indexed citations
4.
Saeki, Hidehisa, Tomotaka Mabuchi, Akihiko Asahina, et al.. (2023). English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of Dermatology. 50(5). e138–e150. 6 indexed citations
5.
Ohata, Chika, Yasumasa Kanai, Kenta Murotani, et al.. (2023). Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study. Dermatology and Therapy. 13(4). 1039–1052. 7 indexed citations
6.
Saeki, Hidehisa, Tomotaka Mabuchi, Akihiko Asahina, et al.. (2022). English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of Dermatology. 50(2). e41–e68. 25 indexed citations
7.
Mabuchi, Tomotaka, et al.. (2018). Case of Omenn Syndrome with a Novel RAG2 Missense Mutation. 3(1). 1 indexed citations
8.
Kobayashi, Masaki, Keigo Kawabata, Ayumi Kusaka-Kikushima, et al.. (2016). Cartilage Oligomeric Matrix Protein Increases in Photodamaged Skin. Journal of Investigative Dermatology. 136(6). 1143–1149. 11 indexed citations
9.
Mabuchi, Tomotaka & N. Hirayama. (2016). Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis. Journal of Investigative Dermatology. 136(9). 1901–1903. 31 indexed citations
10.
Mabuchi, Tomotaka. (2013). Emerging therapies in psoriasis. 65(1). 141–142.
11.
Mabuchi, Tomotaka, et al.. (2012). Random skin biopsy of intravascular large B-cell lymphoma: a case report.. PubMed. 37(3). 75–6. 9 indexed citations
12.
Kato, Masayuki, et al.. (2012). A case of Myxofibrosarcoma. Skin Cancer. 27(2). 162–165.
13.
Mabuchi, Tomotaka, Tej Pratap Singh, Tomonori Takekoshi, et al.. (2012). CCR6 Is Required for Epidermal Trafficking of γδ-T Cells in an IL-23-Induced Model of Psoriasiform Dermatitis. Journal of Investigative Dermatology. 133(1). 164–171. 110 indexed citations
14.
Oka, Akira, Tomotaka Mabuchi, Akira Ozawa, & Hidetoshi Inoko. (2012). Current understanding of human genetics and genetic analysis of psoriasis. The Journal of Dermatology. 39(3). 231–241. 46 indexed citations
15.
Ikeda, Shigaku, Tadashi Terui, Maki Ozawa, et al.. (2011). A novel splicing variant of CADM2 as a protective transcript of psoriasis. Biochemical and Biophysical Research Communications. 412(4). 626–632. 6 indexed citations
16.
Mabuchi, Tomotaka, et al.. (2011). Chemokine receptors in the pathogenesis and therapy of psoriasis. Journal of Dermatological Science. 65(1). 4–11. 79 indexed citations
17.
Mabuchi, Tomotaka, et al.. (2007). A case of blastic NK‐cell lymphoma. International Journal of Dermatology. 46(7). 722–726. 4 indexed citations
18.
Kulski, Jerzy K., M. Bellgard, Ross Taplin, et al.. (2005). Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. Journal of Molecular Medicine. 83(12). 964–975. 54 indexed citations
19.
Matsuzaka, Yasunari, Koichi Okamoto, Yoko Yoshikawa, et al.. (2004). hRDH-E2 gene polymorphisms, variable transcriptional start sites, and psoriasis. Mammalian Genome. 15(8). 668–675. 5 indexed citations
20.
Umezawa, Yoshinori, et al.. (2003). Management of Cyclosporine Therapy Based on TDM (Therapeutic Drug Monitoring) for Psoriasis. The Nishinihon Journal of Dermatology. 65(2). 183–187. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satveer K. Mahil Breakdown of academic impact, for papers by Antonella Di Cesare Breakdown of academic impact, for papers by Hekla Sigmundsdóttir Breakdown of academic impact, for papers by Pablo Coto‐Segura Breakdown of academic impact, for papers by Luis F. Santamaria‐Babí Breakdown of academic impact, for papers by Melodie Young Breakdown of academic impact, for papers by Luca Potestio Breakdown of academic impact, for papers by Gamze Pişkin Breakdown of academic impact, for papers by Inna Cueto Breakdown of academic impact, for papers by Sabatino Pallotta
Rankless by CCL
2026